Aphios Corporation-Product Pipeline Review-2015

Aphios Corporation-Product Pipeline Review-2015

  • Products Id :- GMDHC06907CDB
  • |
  • Pages: 47
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Aphios Corporation-Product Pipeline Review-2015


Global Markets Direct's, 'Aphios Corporation-Product Pipeline Review-2015', provides an overview of the Aphios Corporation's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Aphios Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Aphios Corporation including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Aphios Corporation's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Aphios Corporation's pipeline products

Reasons To Buy

Evaluate Aphios Corporation's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Aphios Corporation in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Aphios Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Aphios Corporation and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Aphios Corporation

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Aphios Corporation and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Aphios Corporation Snapshot 6

Aphios Corporation Overview 6

Key Information 6

Key Facts 6

Aphios Corporation-Research and Development Overview 7

Key Therapeutic Areas 7

Aphios Corporation-Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products-Monotherapy 11

Pipeline Products-Partnered Products 12

Partnered Products/Combination Treatment Modalities 13

Aphios Corporation-Pipeline Products Glance 14

Aphios Corporation-Clinical Stage Pipeline Products 14

Phase I Products/Combination Treatment Modalities 14

Aphios Corporation-Early Stage Pipeline Products 15

Preclinical Products/Combination Treatment Modalities 15

Discovery Products/Combination Treatment Modalities 16

Aphios Corporation-Drug Profiles 17

APH-0812 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

AMPI-109 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

APH-0201 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

APH-0701 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

APH-0907 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

APH-0911 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

APH-0912 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

APH-1305 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

camptothecin nanosomal 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

dronabinol 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

HIV vaccine 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

Hypericin 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

paclitaxel nanosomal 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

paclitaxel phospholipid nanosomal 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

Sperol 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

APH-0202 32

Product Description 32

Mechanism of Action 32

R&D Progress 32

APH-0804 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

APP-0205 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

APP-069 35

Product Description 35

Mechanism of Action 35

R&D Progress 35

APP-309 36

Product Description 36

Mechanism of Action 36

R&D Progress 36

APP-401 37

Product Description 37

Mechanism of Action 37

R&D Progress 37

Marinus 38

Product Description 38

Mechanism of Action 38

R&D Progress 38

Aphios Corporation-Pipeline Analysis 39

Aphios Corporation-Pipeline Products by Target 39

Aphios Corporation-Pipeline Products by Route of Administration 40

Aphios Corporation-Pipeline Products by Molecule Type 41

Aphios Corporation-Pipeline Products by Mechanism of Action 42

Aphios Corporation-Recent Pipeline Updates 43

Aphios Corporation-Dormant Projects 44

Aphios Corporation-Locations And Subsidiaries 45

Head Office 45

Appendix 46

Methodology 46

Coverage 46

Secondary Research 46

Primary Research 46

Expert Panel Validation 46

Contact Us 46

Disclaimer 47

List of Tables

Aphios Corporation, Key Information 6

Aphios Corporation, Key Facts 6

Aphios Corporation-Pipeline by Indication, 2015 8

Aphios Corporation-Pipeline by Stage of Development, 2015 10

Aphios Corporation-Monotherapy Products in Pipeline, 2015 11

Aphios Corporation-Partnered Products in Pipeline, 2015 12

Aphios Corporation-Partnered Products/ Combination Treatment Modalities, 2015 13

Aphios Corporation-Phase I, 2015 14

Aphios Corporation-Preclinical, 2015 15

Aphios Corporation-Discovery, 2015 16

Aphios Corporation-Pipeline by Target, 2015 39

Aphios Corporation-Pipeline by Route of Administration, 2015 40

Aphios Corporation-Pipeline by Molecule Type, 2015 41

Aphios Corporation-Pipeline Products by Mechanism of Action, 2015 42

Aphios Corporation-Recent Pipeline Updates, 2015 43

Aphios Corporation-Dormant Developmental Projects,2015 44

List of Figures

Aphios Corporation-Pipeline by Top 10 Indication, 2015 8

Aphios Corporation-Pipeline by Stage of Development, 2015 10

Aphios Corporation-Monotherapy Products in Pipeline, 2015 11

Aphios Corporation-Pipeline by Top 10 Target, 2015 39

Aphios Corporation-Pipeline by Top 10 Route of Administration, 2015 40

Aphios Corporation-Pipeline by Top 10 Molecule Type, 2015 41

Aphios Corporation-Pipeline Products by Top 10 Mechanism of Action, 2015 42

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

Current R&D Portfolio of Aphios Corporation; Aphios Corporation - Key Therapeutics; Aphios Corporation - Pipeline Overview and Promising Molecules; Aphios Corporation - News; Aphios Corporation - Latest Updates; Aphios Corporation - Pipeline; Aphios Corporation - Discontinued/Dormant Projects

select a license
Single User License
USD 1500 INR 108555
Site License
USD 3000 INR 217110
Corporate User License
USD 4500 INR 325665



I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com